Role of the data safety and monitoring board in an international trial

被引:0
|
作者
Caceres, Carlos F.
Coates, Thomas J.
Hartwell, Tyler D.
Kasprzyk, Danuta
Kelly, Jeffrey A.
Kozlov, Andrei P.
Pequegnat, Willo
Rotheram-Borus, Mary Jane
Solomon, Suniti
Woelk, Godfrey
Wu, Zunyou
机构
[1] Johns Hopkins Univ, Baltimore, MD 21218 USA
[2] Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA 90024 USA
[3] Med Coll Wisconsin, Milwaukee, WI 53226 USA
[4] St Petersburg State Univ, Biomed Ctr, St Petersburg, Russia
[5] NIMH, Bethesda, MD 20892 USA
[6] Univ Zimbabwe, Sch Med, Harare, Zimbabwe
[7] Yale Univ, New Haven, CT 06520 USA
[8] Stanford Univ, Stanford, CA 94305 USA
[9] Univ Calif San Francisco, San Francisco Dept Publ Hlth, San Francisco, CA 94143 USA
[10] Miriam Hosp, Providence, RI 02906 USA
[11] Univ N Carolina, Chapel Hill, NC 27515 USA
[12] SAHAI Trust, Madras, Tamil Nadu, India
[13] Natl Ctr STD & Leprosy Control, Nanjing, Peoples R China
[14] Univ Arizona, Tucson, AZ 85721 USA
关键词
community popular opinion leader; data safety and monitoring board; sexually transmitted diseases; HIV;
D O I
暂无
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Objective: To describe the composition and role of the data safety and monitoring board (DSMB) for the National Institute of Mental Health (NIMH) Collaborative HIV/STD Prevention Trial. Design: NIMH appointed to the DSMB nine members representing the following areas of expertise: prevention science, ethnography, infectious diseases (especially HIV and sexually transmitted diseases), laboratory diagnostics, clinical practice, methodology, international trial experience, statistics, and ethics. Methods: The DSMB assessed the overall study for any concern about plans or implementation and reviewed cumulative study data to evaluate the safety of study participants, the ongoing conduct of the study, and the scientific validity and integrity of the Trial. Because of the Trial's international scope, the DSMB examined the effects of cultural differences on study implementation and fidelity. Results: Among the DSMB recommendations that strengthened the Trial was one to conduct initial epidemiological studies of the venues selected for the intervention to verify risk and to establish intraclass correlation coefficients that could be used to calculate appropriate sample sizes. Conclusions: The DSMB played a critical role in this Trial. Because members have the expertise required to monitor the Trial, are not involved in the daily management of the Trial, and can review interim analyses and adverse event reports, they are in an excellent position to provide expert advice to ensure that the Trial's goals are achieved and that NIH funds are well invested. (C) 2007 Lippincott Williams & Wilkins.
引用
收藏
页码:S99 / S102
页数:4
相关论文
共 50 条
  • [1] The Role of the Data and Safety Monitoring Board in a Clinical Trial: The CRISIS Study
    Holubkov, Richard
    Casper, T. Charles
    Dean, J. Michael
    Anand, K. J. S.
    Zimmerman, Jerry
    Meert, Kathleen L.
    Newth, Christopher J. L.
    Berger, John
    Harrison, Rick
    Willson, Douglas F.
    Nicholson, Carol
    PEDIATRIC CRITICAL CARE MEDICINE, 2013, 14 (04) : 374 - 383
  • [2] Learning from a Trial Stopped by a Data and Safety Monitoring Board
    Harrington, David
    Drazen, Jeffrey M.
    NEW ENGLAND JOURNAL OF MEDICINE, 2018, 378 (21): : 2031 - 2032
  • [3] The role of data and safety monitoring board in clinical trials: A systematic review
    Li, LC
    Hutton, E
    Jong, P
    Ross, S
    Hannah, M
    JOURNAL OF RHEUMATOLOGY, 2003, 30 (08) : 1883 - 1883
  • [4] Data Safety Monitoring Board (DSMB)
    Welch, KMA
    AMYOTROPHIC LATERAL SCLEROSIS AND OTHER MOTOR NEURON DISORDERS, 2004, 5 : 46 - 47
  • [5] How to improve expert participation in the Data Safety Monitoring Board of a clinical trial?
    Nguyen, T. H.
    Nguon, M.
    Landel, V.
    Lapeyre, M.
    Mollard, M.
    Blanc, E.
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2021, 35 : 162 - 162
  • [6] Forming your phase III trial's data and safety monitoring board: A perspective on safety
    Wittes, J
    JOURNAL OF INVESTIGATIVE MEDICINE, 2004, 52 (07) : 453 - 458
  • [7] On being the statistician on a data and safety monitoring board
    Whitehead, J
    STATISTICS IN MEDICINE, 1999, 18 (24) : 3425 - 3434
  • [8] What is the profile of Data Safety Monitoring Board experts?
    Serrano, C.
    Nguyen, T. H.
    Landel, V.
    Nguon, M.
    Blanc, E.
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2021, 35 : 155 - 155
  • [9] Data and safety monitoring in the Delta trial
    Armitage, P
    CONTROLLED CLINICAL TRIALS, 1999, 20 (03): : 229 - 241
  • [10] Data and safety monitoring board deliberations resulting in the early termination of the Monoclonal Antibody Cytomegalovirus Retinitis Trial
    Gilpin, AMK
    Holbrook, JT
    Jabs, DA
    Meinert, CL
    CONTROLLED CLINICAL TRIALS, 2003, 24 (01): : 92 - 98